S. Wilkinson

First name
S.
Last name
Wilkinson
Wilkinson, S. ., Douglas, I. J., Williamson, E. ., Stirnadel-Farrant, H. A., Fogarty, D. ., Pokrajac, A. ., … Tomlinson, L. A. (2018). Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care. Clin Epidemiol. http://doi.org/10.2147/clep.s176142
Wilkinson, S. ., Douglas, I. ., Stirnadel-Farrant, H. ., Fogarty, D. ., Pokrajac, A. ., Smeeth, L. ., & Tomlinson, L. . (2018). Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017. BMJ Open. http://doi.org/10.1136/bmjopen-2018-022768
Wilkinson, S. ., Williamson, E. ., Pokrajac, A. ., Fogarty, D. ., Stirnadel-Farrant, H. ., Smeeth, L. ., … Tomlinson, L. A. (2020). Comparative effects of sulfonylureas, DPP4is and SGLT2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care. Diabetes Obes Metab. http://doi.org/10.1111/dom.13970
Bidulka, P. ., O\textquoterightNeill, S. ., Basu, A. ., Wilkinson, S. ., Silverwood, R. J., Charlton, P. ., … Grieve, R. . (2021). Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study. BMJ Open. http://doi.org/10.1136/bmjopen-2020-046912